Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2016, Article ID 5029278, 6 pages
http://dx.doi.org/10.1155/2016/5029278
Research Article

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage

Department of Ophthalmology, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

Received 6 August 2016; Accepted 22 November 2016

Academic Editor: Kathrin Hartmann

Copyright © 2016 Yu Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Blencowe, J. E. Lawn, T. Vazquez, A. Fielder, and C. Gilbert, “Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010,” Pediatric Research, vol. 74, no. 1, pp. 35–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. W. V. Good, “Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity randomized trial,” Transactions of the American Ophthalmological Society, vol. 102, pp. 233–248, 2004. View at Google Scholar
  3. W. V. Good, R. J. Hardy, V. Dobson et al., “Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial,” Archives of Ophthalmology, vol. 121, no. 12, pp. 1684–1696, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Sanghi, M. R. Dogra, D. Katoch, and A. Gupta, “Aggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulation,” American Journal of Ophthalmology, vol. 155, no. 1, pp. 159–164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Azuma, M. Ito, T. Yokoi, Y. Nakayama, and S. Nishina, “Visual outcomes after early vitreous surgery for aggressive posterior retinopathy of prematurity,” JAMA Ophthalmology, vol. 131, no. 10, pp. 1309–1313, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-J. Kim, M. J. Kim, and Y. S. Yu, “The risk for retinal detachment associated with hemorrhages pre- and postlaser treatment in retinopathy of prematurity,” Retina, vol. 28, no. 10, pp. 1451–1457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Hutcheson, A. T. Q. Nguyen, M. W. Preslan, N. J. Ellish, and S. M. Steidl, “Vitreous hemorrhage in patients with high-risk retinopathy of prematurity,” American Journal of Ophthalmology, vol. 136, no. 2, pp. 258–263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. A. Mintz-Hittner, K. A. Kennedy, and A. Z. Chuang, “Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity,” New England Journal of Medicine, vol. 364, no. 7, pp. 603–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-N. Chen, I. Lian, Y.-C. Hwang et al., “Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab,” Retina, vol. 35, no. 4, pp. 667–674, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. M. Castellanos, S. Schwartz, G. García-Aguirre, and H. Quiroz-Mercado, “Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity,” British Journal of Ophthalmology, vol. 97, no. 7, pp. 816–819, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. H. A. Mintz-Hittner and R. R. Kuffel Jr., “Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone i or posterior zone II,” Retina, vol. 28, no. 6, pp. 831–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. G. E. Quinn, “The international classification of retinopathy of prematurity revisited,” Archives of Ophthalmology, vol. 123, no. 7, pp. 991–999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Hu, M. P. Blair, M. J. Shapiro, S. J. Lichtenstein, J. M. Galasso, and R. Kapur, “Reactivation of retinopathy of prematurity after bevacizumab injection,” Archives of Ophthalmology, vol. 130, no. 8, pp. 1000–1006, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Sanghi, M. R. Dogra, P. Das, A. Vinekar, A. Gupta, and S. Dutta, “Aggressive posterior retinopathy of prematurity in asian indian babies: spectrum of disease and outcome after laser treatment,” Retina, vol. 29, no. 9, pp. 1335–1339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kychenthal, P. Dorta, and X. Katz, “Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes,” Retina, vol. 26, no. 7, pp. S11–S15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Y. Lee, J. B. Chae, S. J. Yang, Y. H. Yoon, and J.-G. Kim, “Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 9, pp. 1257–1262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Arámbulo, G. Dib, J. Iturralde, F. Duran, M. Brito, and J. B. Fortes Filho, “Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity,” Clinical Ophthalmology, vol. 9, pp. 2027–2032, 2015. View at Google Scholar · View at Scopus
  18. Z. Yi, Y. Su, Y. Zhou et al., “Effects of intravitreal ranibizumab in the treatment of retinopathy of prematurity in Chinese infants,” Current Eye Research, vol. 41, no. 8, pp. 1092–1097, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. S. D. Nicoară, C. Nascutzy, C. Cristian et al., “Outcomes and prognostic factors of intravitreal bevacizumab monotherapy in Zone I Stage 3+ and aggressive posterior retinopathy of prematurity,” Journal of Ophthalmology, vol. 2015, Article ID 102582, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. H. A. Mintz-Hittner, M. M. Geloneck, and A. Z. Chuang, “Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy,” Ophthalmology, vol. 123, no. 9, pp. 1845–1855, 2016. View at Publisher · View at Google Scholar
  21. J. J. Chan, C. P. Lam, M. K. Kwok et al., “Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy,” Scientific Reports, vol. 6, Article ID 27082, 2016. View at Publisher · View at Google Scholar
  22. B. A. Darlow, J. L. Hutchinson, D. J. Henderson-Smart, D. A. Donoghue, J. M. Simpson, and N. J. Evans, “Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network,” Pediatrics, vol. 115, no. 4, pp. 990–996, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. B. Yang, E. F. Donovan, and J. R. Wagge, “Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity,” Journal of American Association for Pediatric Ophthalmology and Strabismus, vol. 10, no. 3, pp. 253–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. C. H. Meyer and F. G. Holz, “Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab,” Eye, vol. 25, no. 6, pp. 661–672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. W. C. Wu, C. P. Shih, R. Lien et al., “Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity,” Retina, In press.
  26. B. J. Lee, J. H. Kim, H. Heo, and Y. S. Yu, “Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity,” Eye, vol. 26, no. 7, pp. 903–910, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. R. D. Patel, M. P. Blair, M. J. Shapiro, and S. J. Lichtenstein, “Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity,” Archives of Ophthalmology, vol. 130, no. 6, pp. 801–802, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Honda, H. Hirabayashi, Y. Tsukahara, and A. Negi, “Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 7, pp. 1061–1063, 2008. View at Publisher · View at Google Scholar · View at Scopus